Archives of Iranian Medicine,
Год журнала:
2024,
Номер
27(10), С. 538 - 544
Опубликована: Окт. 1, 2024
Background:
While
cardiovascular
disease
(CVD)
polypills
have
demonstrated
significant
benefits
in
preventing
CVD
events
by
managing
risk
factors
and
improving
patient
adherence,
their
effects
on
blood
glucose
levels,
an
important
factor
for
CVD,
remain
unknown.
Methods:
We
analyzed
data
from
the
PolyIran-Liver
trial,
which
involved
1,508
participants
aged
50
above.
Of
these,
787
were
randomly
assigned
to
receive
a
polypill
(consisting
of
aspirin,
atorvastatin,
hydrochlorothiazide,
valsartan),
while
721
received
usual
care
as
control
group
over
five-year
period.
The
aim
was
determine
whether
there
any
differences
fasting
sugar
(FBS)
levels
between
two
groups
at
baseline,
middle,
end
study.
analysis
focused
three
subgroups:
with
diabetes,
those
metabolic
syndrome
(MetS)
but
without
diabetes
or
MetS.
Results:
total
studied
population,
mean
age
59±6.7
years,
328(22%)
identified
371
(25%)
MetS
809
(54%)
observed
trend
rising
FBS
until
month
30,
followed
subsequent
decline
60.
Participants
exhibited
lower
than
both
time
points,
statistically
all
subgroups
30
MetS-without
60
(mean
difference:
-9.3
mg/dl,
95%
CI:
13.9
-4.6).
Conclusion:
used
this
study
may
potential
delay
onset
patients
more
effectively
general
population.
However,
its
beneficial
diabetic
individuals
require
further
investigation.
Journal of Clinical and Translational Hepatology,
Год журнала:
2024,
Номер
000(000), С. 000 - 000
Опубликована: Ноя. 4, 2024
With
the
rising
epidemic
of
obesity,
metabolic
syndrome,
and
type
2
diabetes
mellitus
in
China,
dysfunction-associated
non-alcoholic
fatty
liver
disease
has
become
most
prevalent
chronic
disease.
This
condition
frequently
occurs
Chinese
patients
with
alcoholic
hepatitis
B.
To
address
impending
public
health
crisis
its
underlying
issues,
Society
Hepatology
Medical
Association
convened
a
panel
clinical
experts
to
revise
update
"Guideline
prevention
treatment
(2018,
China)".
The
new
edition,
titled
for
(Version
2024)",
offers
comprehensive
recommendations
on
key
including
screening
monitoring,
diagnosis
evaluation,
treatment,
follow-up
steatotic
Metabolic
is
now
preferred
English
term
used
interchangeably
Additionally,
guideline
emphasizes
importance
multidisciplinary
collaboration
among
hepatologists
other
specialists
manage
cardiometabolic
disorders
effectively.
ABSTRACT
Background
Gamma‐glutamyl
transferase
(GGT)
has
been
shown
to
have
associations
with
several
diseases
including
cancers.
Previous
studies
investigated
the
effect
of
GGT
levels
on
gastrointestinal
(GI)
cancer
incidence.
We
aim
systematically
investigate
these
provide
better
insights
into
interrelationship
between
and
GI
Methods
Online
databases
were
searched
find
relevant
investigating
different
levels'
effects
incidence
cancers
colorectal,
esophageal,
liver,
pancreas,
gastric,
biliary
duct
Random‐effect
meta‐analysis
was
conducted
pool
hazard
ratios
(HRs)
quartiles
(Qs)
Results
A
total
26
included
in
final
review,
12
which
underwent
that
11
million
patients.
Based
meta‐analysis,
Q4
patients
had
a
69%
higher
(HR
1.69,
95%
CI
1.41–2.02,
p
‐value
<
0.001).
The
ratio
significance
also
similar
for
Q3
1.22,
1.15–1.30,
0.001)
Q2
1.10,
1.05–1.16,
=0.002)
GGT.
Colorectal
liver
showed
among
Q2,
Q3,
compared
Q1.
In
pancreas
bile
cancers,
only
significantly
HR.
statistically
significant
gastric
Conclusion
Higher
correlate
rates
incidence,
especially
colorectal
hepatic
Future
should
this
biomarker's
potential
role
risk
assessment
digestive
Signal Transduction and Targeted Therapy,
Год журнала:
2025,
Номер
10(1)
Опубликована: Фев. 4, 2025
Abstract
As
a
highly
complex
organ
with
digestive,
endocrine,
and
immune-regulatory
functions,
the
liver
is
pivotal
in
maintaining
physiological
homeostasis
through
its
roles
metabolism,
detoxification,
immune
response.
Various
factors
including
viruses,
alcohol,
metabolites,
toxins,
other
pathogenic
agents
can
compromise
function,
leading
to
acute
or
chronic
injury
that
may
progress
end-stage
diseases.
While
sharing
common
features,
diseases
exhibit
distinct
pathophysiological,
clinical,
therapeutic
profiles.
Currently,
contribute
approximately
2
million
deaths
globally
each
year,
imposing
significant
economic
social
burdens
worldwide.
However,
there
no
cure
for
many
kinds
of
diseases,
partly
due
lack
thorough
understanding
development
these
Therefore,
this
review
provides
comprehensive
examination
epidemiology
characteristics
covering
spectrum
from
conditions
manifestations.
We
also
highlight
multifaceted
mechanisms
underlying
initiation
progression
spanning
molecular
cellular
levels
networks.
Additionally,
offers
updates
on
innovative
diagnostic
techniques,
current
treatments,
potential
targets
presently
under
clinical
evaluation.
Recent
advances
pathogenesis
hold
critical
implications
translational
value
novel
strategies.
International Journal of Cardiology Cardiovascular Risk and Prevention,
Год журнала:
2025,
Номер
25, С. 200400 - 200400
Опубликована: Апрель 6, 2025
Premature
deaths
account
for
about
half
of
all
fatalities
in
developing
countries.
In
low-
and
middle-income
countries,
cardiovascular
diseases
have
consistently
been
the
primary
cause
premature
mortality
men
women
during
past
three
decades.
Current
evidence
indicates
that
fixed-dose
combination
therapy,
so-called
Polypill,
effectively
reduces
burden
diseases,
with
greater
benefits
observed
combinations
include
aspirin.
Polypill
demonstrates
high
adherence
an
acceptable
safety
profile,
adverse
drug
events
being
comparable
between
groups
receiving
treatment
those
control
group.
Therefore,
this
paper
advocates
broader
implementation
low
emphasizing
its
efficacy
secondary
prevention
diseases.
The
strategy
could
also
benefit
high-risk
special
conditions,
such
as
non-alcoholic
fatty
liver
disease
chronic
kidney
disease.
cost-effectiveness
potential
to
address
health
inequities
countries
underscore
value
a
public
strategy.
Policymakers
are
encouraged
consider
viable
option
enhance
outcomes
reduce
low-resource
settings.
Diabetology & Metabolic Syndrome,
Год журнала:
2025,
Номер
17(1)
Опубликована: Март 28, 2025
The
Cardiovascular-kidney-metabolic
(CKM)
syndrome
is
a
health
disorder
caused
by
interactions
between
cardiovascular
disease,
kidney
and
metabolism-related
risk
factors.
stress
hyperglycemia
ratio
(SHR)
has
been
shown
to
correlate
with
the
prognosis
of
participants
diabetes
mellitus,
heart
failure,
myocardial
infarction.
However,
predictive
value
SHR
in
CKM
population
unclear
requires
further
exploration.
This
study
analyzed
19,345
from
National
Health
Nutrition
Examination
Survey
(1999–2018).
was
staged
according
American
Heart
Association
(AHA)
guidelines.
calculated
using
fasting
blood
glucose
(FBG)
glycated
hemoglobin
type
A1c
(HbA1c).
Participants
were
grouped
into
four
quartiles
based
on
SHR.
primary
secondary
outcomes
all-cause
mortality
mortality,
respectively.
Kaplan-Meier
survival
curves
Cox
proportional
hazard
regression
models
used
evaluate
association
outcomes.
Then,
potential
nonlinear
relationship
explored
restricted
cubic
spline
(RCS)
analysis.
We
also
performed
subgroup
analyses
assess
effects
different
variables.
A
total
2,736
deaths
699
recorded
during
median
follow-up
period
115
months.
analysis
revealed
that
quartile
2
had
lowest
for
both
(Log
Rank
P
<
0.05).
Multivariate
demonstrated
2nd
(HR
=
0.84,
95%
CI
0.73–0.97,
0.015)
highest
4th
1.19,
1.03–1.37,
0.018),
compared
1st
group
RCS
curve
U-shape
points
0.89
0.91,
strongly
correlated
population,
high
or
low
increasing
death.
index
shows
great
predicting
death
this
population.
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
AbstractBackground
Adherence
to
statin
therapy
is
crucial
for
reducing
the
recurrence
of
cardiovascular
events.
Numerous
methods
exist
measure
medication
adherence,
including
those
based
on
prescription
data,
patient
self-report,
counting,
and
direct
methods.
It
important
determine
which
these
are
appropriate
use
in
clinical
practice.
This
systematic
review
aimed
identify
used
adherence
persistence
statins
patients
undergoing
secondary
prevention
evaluate
validity
indicators
Methods
included
studies
reporting
and/or
prevention.
Medline,
Embase,
Scopus
databases
were
searched
from
inception
February,
2025.
Rayyan
was
study
selection
extraction
data
processes.
Validity
adherence/persistence
collected,
it
reported.
Risk
bias
method
evaluated
using
COSMIN
(Consensus-based
Standards
Selection
Health
Measurement
Instruments)
tool.
Results
A
total
77
included.
Regarding
measurement,
most
frequently
refill
records
(n
=
55)
self-report
20).
Electronic
monitoring
2),
self-perceived
by
physician
1),
pill
counting
1)
less
Direct
methods,
HPLC-MS/MS,
combination
with
other
indirect
5).
For
measuring
persistence,
predominant
9),
while
three
studies,
one
a
standardized
questionnaire.
Several
have
different
populations
medications.
Only
provides
MAT
questionnaire
specifically
adapted
statins.
Conclusions
The
predominantly
indirect,
relying
supply
Pill
electronic
monitoring,
measurement
via
LC-MS/MS
commonly
used.
Persistence
primarily
measured
through
records.
None
validated,
thus
their
not
recommended.
There
need
new
validated
tools,
incorporating
gender
perspective,
this
population.
Systematic
registration:
CRD42023463981.
Diagnostics,
Год журнала:
2025,
Номер
15(10), С. 1208 - 1208
Опубликована: Май 10, 2025
Background:
This
study
investigates
the
link
between
metabolic
dysfunction-associated
fatty
liver
disease
(MAFLD)
and
coronary
artery
(CAD)
using
ultrasonographic
indicator
(US-FLI)
to
assess
steatosis.
Methods:
A
total
of
204
patients
were
included,
with
hepatic
steatosis
evaluated
through
ultrasound
characteristics,
diagnosing
when
US-FLI
was
≥2.
CAD
severity
determined
SYNTAX
score
(SS),
categorizing
100
into
mild
(SS
≤
22)
moderate-severe
(MS)
≥
23)
groups.
The
association
SS
in
MAFLD
multivariate
logistic
regression
model.
receiver
operating
characteristic
curve
applied
determine
accuracy,
sensitivity,
specificity
predicting
SS.
Results:
In
analysis,
an
independent
predictor
group
(OR
=
1.194,
95%
CI:
1.008–1.414,
p
0.040)
MS
1.262,
1.025–1.553,
0.028).
a
value
2
found
be
optimal
threshold
point
for
(AUC
0.620,
0.509–0.713,
0.039),
sensitivity
65.22%
55.56%.
diagnostic
performance
significantly
improved
combined
type
diabetes
mellitus
(T2DM)
0.732,
0.632–0.832,
<
0.001),
77.78%.
Conclusions:
independently
positively
associated
severity.
T2DM
had
better
CAD.
Systematic Reviews,
Год журнала:
2025,
Номер
14(1)
Опубликована: Май 15, 2025
Adherence
to
statin
therapy
is
crucial
for
reducing
the
recurrence
of
cardiovascular
events.
Numerous
methods
exist
measure
medication
adherence,
including
those
based
on
prescription
data,
patient
self-report,
counting,
and
direct
methods.
It
important
determine
which
these
are
appropriate
use
in
clinical
practice.
This
systematic
review
aimed
identify
used
adherence
persistence
statins
patients
undergoing
secondary
prevention
evaluate
validity
indicators
included
studies
reporting
and/or
prevention.
Medline,
Embase,
Scopus
databases
were
searched
from
inception
February
2025.
Rayyan
was
study
selection
extraction
data
processes.
Validity
adherence/persistence
collected;
it
reported.
Risk
bias
method
evaluated
using
COSMIN
(Consensus-based
Standards
Selection
Health
Measurement
Instruments)
tool.
A
total
77
included.
Regarding
measurement,
most
frequently
refill
records
(n
=
55)
self-report
20).
Electronic
monitoring
2),
self-perceived
by
physician
1),
pill
counting
1)
less
Direct
methods,
HPLC-MS/MS,
combination
with
other
indirect
5).
For
measuring
persistence,
predominant
9),
while
three
studies,
one
a
standardized
questionnaire.
Several
have
different
populations
medications.
Only
provides
MAT
questionnaire
specifically
adapted
statins.
The
predominantly
indirect,
relying
supply
Pill
electronic
monitoring,
measurement
via
LC-MS/MS
commonly
used.
Persistence
primarily
measured
through
records.
None
validated;
thus,
their
not
recommended.
There
need
new
validated
tools,
incorporating
gender
perspective,
this
population.
PROSPERO
CRD42023463981.